TrianglePUBLICATIONS · 11167793
A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Br J Haematol
- Publication date
- 2001 Jan
- First author
- Jackson G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Jackson G
- type
- Author
- name
- Taylor P
- type
- Author
- name
- Smith GM
- type
- Author
- name
- Marcus R
- type
- Author
- name
- Smith A
- type
- Author
- name
- Chu P
- type
- Author
- name
- Littlewood TJ
- type
- Author
- name
- Duncombe A
- type
- Author
- name
- Hutchinson M
- type
- Author
- name
- Mehta AB
- type
- Author
- name
- Johnson SA
- type
- Author
- name
- Carey P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Jackson G
- type
- Author
- name
- Taylor P
- type
- Author
- name
- Smith GM
- type
- Author
- name
- Marcus R
- type
- Author
- name
- Smith A
- type
- Author
- name
- Chu P
- type
- Author
- name
- Littlewood TJ
- type
- Author
- name
- Duncombe A
- type
- Author
- name
- Hutchinson M
- type
- Author
- name
- Mehta AB
- type
- Author
- name
- Johnson SA
- type
- Author
- name
- Carey P
- type
- Author
- bibliography ids
- nci-bib-5be8027f4a88dd2d1dea0e29
- book metadata
- content sha256
- 50e46abf12cf11b32395b81aa05736bacde0f83fb2f83cda5a7a601811c72034
- document type
- citation
- dois
- 10.1046/j.1365-2141.2001.02551.x
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11167793
- immutable id
- pubmed:11167793@50e46abf12cf11b32395b81aa05736bacde0f83fb2f83cda5a7a601811c72034
- journal
- abbreviation
- Br J Haematol
- issn electronic
- Source null
- issn print
- 0007-1048
- issue
- 1
- name
- British journal of haematology
- nlm unique id
- 0372544
- pages
- 127-37
- volume
- 112
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11167793
- provenance
- batch id
- 30d2cd7affbbb92b6784
- provider
- NCBI PubMed ESummary
- record sha256
- fb4791be6a987f5a01ca44f77a82d0e80be47eff4bf1e530da5a564ddc320aff
- response sha256
- ae7ed930f8b43c9e34eeae02f278f33f49c15777b81f742392c120eb64949120
- retrieved at
- 2026-09-09T23:45:39.779418+00:00
- publication date
- display
- 2001 Jan
- precision
- month
- year
- 2001
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.
Preserved source evidence · Not medical advice